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ABSTRACT
Background and objectives: Gastro-oesophageal reflux
disease (GORD) is a common gastrointestinal disorder
with a genetic component. Our aim was to identify
genetic factors associated with GORD.
Patients and methods: Four separate patient cohorts
were analysed using a step-wise approach. (1) Whole
genome linkage analysis was performed in 36 families.
(2) Candidate genes were tested for GORD association in
a trio cohort. (3) Genetic association was replicated in a
case–control cohort. We also investigated genetic
association to hiatus hernia (HH). (4) Protein expression
was analysed in oesophageal biopsies.
Results: A region on chromosome 2, containing collagen
type III alpha 1 (COL3A1), was identified (LOD=3.3) in
families with dominant transmission of GORD, stratified
for hiatus hernia (HH). COL3A1 showed significant
association with GORD in an independent paediatric trio
cohort (pcorr=0.003). The association was male specific
(pcorr=0.018). The COL3A1 association was replicated in
an independent adult case control cohort (pcorr=0.022).
Moreover, male specific association to HH (pcorr=0.019)
was found for a SNP not associated to GORD. Collagen
type III protein was more abundant in oesophageal
biopsies from male patients with GORD (p=0.03).
Conclusion: COL3A1 is a disease-associated gene in
both paediatric and adult GORD. Furthermore, we show
that COL3A1 is genetically associated with HH in adult
males. The GORD- and HH-associated alleles are different,
indicating two separate mechanisms leading to disease.
Our data provides new insight into GORD aetiology,
identifying a connective tissue component and indicating
a tissue remodelling mechanism in GORD. Our results
implicate gender differences in the genetic risk for both
for GORD and HH.
Gastro-oesophageal reflux disease (GORD) is char-
acterised by a retrograde movement of stomach
contents into the oesophagus, leading to symp-
toms such as heartburn and regurgitation.
1 In
severe cases, the disease causes tissue erosion and
inflammation in the oesophageal mucosal lining.
GORD is increasingly common in the Western
world, with a prevalence of 25–40% in population-
based studies.
23 Patients suffering from GORD
have a severely impaired quality of life,
4 and the
cost to the society is substantial.
5
The establishment of diagnostic criteria for
GORD is made complicated by the fact that
patients with GORD represent a heterogeneous
patient group. Apart from heartburn and
acid regurgitation, diverse additional symptoms,
including extra-oesophageal manifestations, have
been recognised as important disease compo-
nents.
2 Today, diagnosis is generally based on
symptomatic presentation complemented by
endoscopic and pH probe findings together with
data from validated multidimensional question-
naires.
6 Less than half of the patients suffer from
erosive reflux disease, characterised by mucosal
damage in the oesophagus. However, the majority
of patients have non-erosive reflux disease, and
experience typical GORD symptoms without
visible oesophageal injury.
7
Epidemiological studies have pinpointed a num-
ber of lifestyle-related factors affecting the disease.
2
One such risk factor is hiatus hernia (HH), a
condition characterised by a protrusion of the
upper part of the stomach into the thorax through
a tear or weakness in the diaphragm.
89HH leads to
reflux episodes through an attenuation of the
pressure barrier, constituted by the lower oesopha-
geal sphincter in conjunction with the dia-
phragm.
10 Interestingly, there are data indicating
a genetic contribution to the development of HH.
11
The age of onset of GORD is variable and many
individuals develop the disease during childhood.
GORD is the most common oesophageal disorder
of children, affecting about 11% of all infants
during their first year of life.
12 It has been suggested
that adult GORD may sometimes originate in
childhood.
3 13–16 The disease aetiology is further
complicated by a substantial genetic contribution
as shown by; familial clustering,
17 autosomal
dominant familial transmission of disease,
18 19 as
well as twin studies.
20–22 Hu and colleagues
addressed this and identified a linked region on
chromosome 13q14 in families with severe paedia-
tric GORD.
18 Orenstein and colleagues, however,
failed to replicate this linkage finding in a different
GORD family material.
19 Although this region is
relatively well defined, subsequent work has, so
far, not led to the identification of a disease
susceptibility gene on chromosome 13q14.
23
The aim of this study was to identify genes
associated with GORD and to investigate if these
genes are shared between paediatric and adult
forms of the disease. To address this, four separate
patient cohorts were examined in a step-wise
manner. First, genome-wide linkage analysis was
carried out in families displaying an apparently
dominant inheritance of the disease. Next, gene
association analyses were performed in a paediatric
trio cohort, followed by replication of results in an
adult case–control cohort. Lastly, protein levels
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healthy controls.
METHODS
Patient collections
Informed consent was obtained before enrolment. All data and
DNA/tissue samples were coded. Ethical approval was obtained
for all patient collections.
Families
Enrolment of patients was done at the Gastroenterology Unit at
Women’s and Children’s Hospital (WCH, Adelaide, Australia),
from 2001 to 2005 by identifying children (age up to 18)
diagnosed with GORD having at least one of the following
criteria within the last 5 years: an abnormal finding from
endoscopic examination or 24 h oesophageal pH test or having
been subject to fundoplication. Probands were identified by
examination of patient records at WCH and by contacting the
local GORD support association. Parents of the proband were
contacted and the family was enrolled if a positive family
history of GORD could be shown. Disease status was assessed
via physician diagnosis often with results of previously
performed investigations.
24–26 Patients with a medical condition
known to predispose to GORD were excluded. HH was
identified through previously performed endoscopic examina-
tion and/or radiological contrast studies.
Trios
The trio cohort consists of paediatric patients diagnosed with
GORDbetween3 monthsand17 yearsof agewithoutconditions
predisposing toGORD,andtheirparents.ThediagnosisofGORD
relied on the following: a paediatric gastroenterologist’s evalua-
tion of symptoms to be consistent with GORD, in addition to
either endoscopic, histological or pH probe determined acid
exposure consistent with GORD and/or a definite and significant
improvement in symptoms of GORD shortly after commencing
anti-reflux treatment. Previous anti-reflux surgery was also
considered as evidence of GORD. Patients were identified from
databases of endoscopy, pH probe and outpatient diagnoses from
the Gastroenterology Unit at WCH.
Adult GORD case–control cohort (Extended Kalixanda)
The Kalixanda cohort is a collection of patients from northern
Sweden where epidemiological factors related to GORD have
been investigated.
27 28 We extended this cohort with 100
patients with GORD from local clinics, resulting in a new
cohort, referred to as the extended Kalixanda cohort. All
individuals went through an endoscopic examination together
with a written questionnaire to diagnose GORD and HH.
28
Adult GORD case–control cohort (EsoNerd)
EsoNerd is a collection of 30 adult GORD cases (18 males) and
eight healthy controls (four males) from western Sweden.
Oesophageal biopsies were obtained and used for gene chip
expression studies and immunohistochemistry (manuscript in
preparation, Pierrou et al).
Healthy volunteers and GORD patients went through pH
metric and endoscopic examinations together with an evalua-
tion of symptoms by a gastroenterologist. Symptom-free
individuals with negative pH metric and endoscopic examina-
tion were chosen as control individuals.
Individuals with GORD symptoms with positive acid
exposure measurements were defined as GORD patients.
Techniques
DNA extraction
DNA was obtained from blood or buccal swabs using Qiagen
Blood DNA extraction kit (Qiagen, Valencia, California, USA)
or was whole genome amplified using GenomPhi (Amersham
Biosciences, Uppsala, Sweden) according to the manufacturer’s
protocol. In cases where the DNA amount was limited, whole
genome amplification was performed by Molecular Staging
(Denver, Colorado, USA) through their Repli-g service.
Genotyping
Microsatellite genotyping was performed in 419 familial DNA
samples using ABI Prism Linkage Mapping set v2.5 HD5 for
DNA fragment analysis (Applied Biosystems, Foster City,
California, USA). Additional microsatellites were amplified
using public primer sequences. The forward primer was ordered
59-fluorophore labelled (Sigma–Genosys, Cambridge, UK) while
the reverse primer was optimised.
29 Size fractioning of DNA
fragments was done in ABI 3700 or 3730 DNA analysers
(Applied Biosystems). Alleles were called using the Genotyper v
3.0 software (Applied Biosystems). The mean distance between
adjacent markers was 4.32 centimorgan (cM) (SD 2.65); range,
0–14.78. SNP genotyping was performed using the TaqMan
assay (Applied Biosystems) and detection in ABI 7900HT
(Applied Biosystems) according to the manufacturer’s recom-
mendations, apart from reducing the total reaction volume to
2.5 ml. All data was analysed with Sequence Detection Systems
software v2.1 (Applied Biosystems).
Table 1 The four different GORD patient collections used in this study to identify collagen type III alpha I (COL3A1) as a susceptibility gene for GORD
Patient collection Origin Usage
Total no of
individuals
No of patients with
GORD
No of healthy
individuals
1 Families Women’s & Children’s
Hospital Adelaide,
Australia
Whole-genome linkage analysis 504 237 168
2 Trios Women’s & Children’s
Hospital Adelaide,
Australia
Genetic association of candidate
genes
1092 364 728
3 Case–control extended
Kalixanda
Karolinska Institute,
Sweden
Genetic association, replication of
findings
741 256 485
4 Case–control EsoNerd Sahlgrenska Hospital,
Sweden
Immunohistochemistry 38 30 8
Summary 2375 887 1389
The family patient collection includes an additional 99 individuals with unknown gastro-oesophageal reflux disease (GORD) status. Affected children of the trios are listed as cases
and their parents as controls. In the extended Kalixanda cohort, 98 individuals were diagnosed with both GORD and hiatus hernia (HH). The remaining 131 HH individuals were added
from the original Kalixanda cohort,
28 producing a separate HH case control material, consisting of 229 cases and the 485 controls.
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Sequencing was performed using the Applied Biosystems 3700 or
3730 automated DNA sequencers (Applied Biosystems) according
to the manufacturer’s recommendation. Sequencing was per-
formed from both directions and analysis was performed using
Sequencher 4.6 (Genecodes, Ann Arbor, Michigan, USA) and
compared with the public genomic sequence (ENST00000304636,
Ensembl release 49). Sequence differences were manually checked
and remaining inconsistencies were resequenced.
Immunohistochemistry
Paraffin-embedded oesophageal tissue sections were treated
according to standard protocols for rehydration and antigen
retrieval. Immunohistochemistry was performed using the
collagen type III specific antibody CL50311AP (Cederlane
Laboratories, Burlington, Ontario, Canada) diluted 1:1500. A
biotinylated secondary antibody was used (DakoCytomation,
Glostrup, Denmark) and the immunoreaction was detected
using the chromogen DAB kit: peroxidase/DAB+, Rabbit/Mouse
(DAKOCytomation Code K5001). Digital images from the
tissue sections were captured and computerised planimetry was
performed using the program Picsara (Euromed Networks,
Stockholm, Sweden). The area of interest (total area) was set
to the epithelial layer, defined to be between the lumen and the
muscularis mucosae. The strong positive immunoreactivation
seen in the submucosa of the biopsies was used as an internal
positive control for the experiment. The staining in the
submucosa was used to confine the positive reaction using the
upper and lower threshold values (Picsara). The identified
setting was then used in all images.
Statistics
Quality control of familial genotype data
Mendelian inconsistencies were detected using PedCheck
(v.1.1).
30 Markers with a large number of errors were either re-
analysed or excluded. Individual erroneous genotypes were
either rechecked or discarded. Hardy–Weinberg testing was
performed in Pedstats (v.0.6.4.
31 Finally, Merlin (v.0.10.2)
32 and,
in the case of the largest family, SimWalk2 (v.2.91)
33–35 were
used to find genotypes due to unlikely recombinations.
Although such genotypes were not automatically discarded, it
was ascertained that they did not influence the linkage peaks.
Quality control of trio and extended Kalixanda genotype data
Mendelian inconsistencies in trio genotypes were detected using
PedCheck (v.1.1). Hardy–Weinberg testing as well as calculation
of descriptive statistics were performed in both Pedstats
(v.0.6.4) and Haploview v.3.2
36 for both the Trios and the
extended Kalixanda cohort.
Linkage analysis
Genetic map positions used in the linkage analysis were
obtained from the Decode map.
37 Markers that did not have
an assigned position were extrapolated into the map based on
physical distance to the flanking markers. Family-wise multi-
point logarithm of the odds ratio (LOD) score curves were
calculated for all autosomal chromosomes and the X chromo-
some using Genehunter v.2.1
38 39 and, in the case of the largest
family, SimWalk2 (v.2.91), assuming a dominant mode of
inheritance. Single point LOD scores were calculated and
compared with the multipoint LOD scores for data consistency.
Linkages are reported according to established guidelines.
40
Sensitivity analysis was performed by (1) varying the para-
meters in the dominant model, (2) assessing an additive mode of
inheritance, and (3) performing non parametric analysis. These
analyses provided no further information and the results are
thus omitted.
Association analysis trios
Single SNPs TDT analysis was performed in Genehunter (v.2.1)
and Haploview (v.3.2). TDT analysis based on haplotypes was
performed in Genehunter (v.2.1). p values adjusted for multiple
Figure 1 Logarithm of the odds ratio (LOD) curve for chromosome 2. Families were stratified for the presence of hiatus hernia and the absence of Barrett’s
oesophagus. One single linkage region was identified with a LOD score of 3.3. The genomic region defined by maximum LOD – 1 is roughly 35 Mbp.
Oesophagus
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mitted and untransmitted haplotypes. For single SNPs,
Haploview (v.3.2) was used, whereas a SAS (v.8.2) macro was
written to obtain adjusted p values for haplotypes, using the
transmit/untransmit-files provided by Genehunter.
Association analysis extended Kalixanda
Case–control analysis based on single SNPs was performed in
SAS (v.8.2) using Fisher’s exact test. p values adjusted for
multiple testing were obtained by permutations of case–control
status. Haplotype analysis was performed in WHAP (v.2.06).
41
Immunohistochemistry
The difference of COL3A1 immunostaining in healthy volun-
teers and patients with GORD from the EsoNerd study was
tested using the Wilcoxon rank sum test in R (v.2.4.1). (http://
www.R-project.org)
RESULTS
Linkage analysis
The four patient collections used in this study are summarised
in table 1. In the initial analysis we investigated the existence of
disease-linked chromosomal regions using the entire family
collection. We collected 36 families, encompassing a total of 504
individuals. Of these, 237 were affected with GORD and 99
were assigned with unknown disease status. The families were
composed of three generations for 22 families, four generations
for 12 families and five generations for two families. Based on
the assumption that different genetic factors are segregating in
different subsets of the families, the material was stratified so
that families where HH was present and Barrett’s oesophagus
was absent were selected for further analysis. In this group of
families, we were able to identify a common linked region on
chromosome 2q24–q33 with a LOD of 3.3 (fig 1). The size of the
region was estimated to be 35 megabase pairs.
Hu and colleagues previously identified linkage at chromo-
some 13q14 to GORD in a family material.
18 None of our 36
families showed evidence for linkage to chromosome 13 (data
not shown). We conclude that the 13q14 locus is not
represented in our material, a finding in line with the results
by Orenstein et al.
19
Genetic association analysis in the trio cohort
Oesophageal gene expression was used to identify candidate
genes within the linkage region (Affymetrix chip U133A & B.,
EsoNerd study, Pierrou et al, manuscript in preparation). Three
genes, CFLAR (CASP8 and FADD-like apoptosis regulator),
COL3A1 (collagen type III alpha I) and ALS2CR2 (amyotrophic
lateral sclerosis 2 (juvenile) chromosome region, candidate 2,
also called STRADB), showed differential expression in oeso-
phageal biopsies from patients with GORD compared with
healthy controls. Genotyping of single nucleotide polymorph-
isms (SNPs) in the three genes in the 364 Trios, followed by
genetic association analysis using transmission disequilibrium
test (TDT), revealed significant association for SNPs only in
COL3A1.
To establish that the association was confined to COL3A1,
we analysed the linkage disequilibrium (LD) structure in the
region by assaying multiple SNPs in COL3A1 as well as in the
flanking genes DIRC1 (disrupted in renal carcinoma 1) and
COL5A2 (collagen, type V, alpha 2). The LD block containing
the disease-associated SNPs only harboured COL3A1. In males,
we identified an associated haplotype in COL3A1 (pcorr of
0.00009; table 2) and an associated SNP (rs6434304) with a pcorr
(p value adjusted for multiple testing) of 0.02 (table 3) . No
single markers or haplotypes showed evidence for association in
females in the Trio cohort.
Genetic association analysis in the case–control cohort
Association analysis was repeated in the adult case–control
cohort consisting of 256 GORD cases, 229 hiatus hernia cases,
and 485 healthy controls. GORD and HH co-existed in 98
individuals. We used the same set of COL3A1 SNPs as
previously, and were able to replicate the GORD association
at a pcorr=0.022 (table 3). No male specific association was
observed.
The linkage to chromosome 2 originated from families
selected for GORD and HH. To investigate if COL3A1 also
was associated with HH, we stratified the case–control cohort
for this phenotype and repeated the analysis. Significant
association was identified in COL3A1. Interestingly, this was
also male specific, with the most significant SNP (rs3134646)
showing a pcorr=0.019 (table 3). It was not possible to validate
our finding in the paediatric trio cohort since HH typically
develops after adolescence.
Mutation analysis of COL3A1
Mutation detection was performed by polymerase chain
reaction (PCR) amplification and DNA sequencing of all 51
exons of COL3A1 as well as 2 kb upstream of the transcription
start site in 48 males and females from the trio cohort. These
individuals represented both contributors and non-contributors
with respect to the observed association. Intron–exon boundaries
were included in the analysis. No amino acid changing mutation
segregating with the disease was identified.
Collagen type III protein expression analysis in oesophageal
biopsies
The abundance of collagen type III was investigated in the
epithelial lining of the distal oesophagus. Biopsies from GORD
patients and healthy controls were obtained and stained with
an antibody directed against human collagen type III. Patients
Table 2 Haplotype analysis using single nucleotide polymorphisms (SNPs) covering collagen type III alpha I (COL3A1)
SNPs Haplotype
Gastro-oesophageal reflux disease
Trios, all Trios, males Case–control, all
p Value p Value pcorr OR (95% CI) p Value OR (95% CI)
4:5 2:1 0.00096 0.00018 0.0026 3.00 (1.63 to 5.50) 0.0026 0.61 (0.43 to 0.85)
4:5 2:2 0.00019 0.000002 0.00009 0.40 (0.26 to 0.59) NS –
5–6 2:2 NS NS NS No data 0.0041 1.42 (1.11 to 1.81)
Highly associated haplotypes were found in both the Trio cohort and in the adult case–control cohort. The association in Trios was found in males only.
CI, confidence interval; NS, not significant OR, odds ratio; pcorr, p value adjusted for multiple testing.
Oesophagus
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(p=0.038 from 30 cases and eight controls. Thus, the data
shows that collagen type III is upregulated in the epithelial
lining of the oesophagus as a consequence of GORD. After
gender stratification, the up regulation remained significant in
males only (p=0.033, 18 cases and 4four controls).
Discussion
In the present study, based on four independent GORD patient
collections (table 1), we show that COL3A1 is associated with
GORD and implicated as being a risk factor for hiatus hernia
(table 3). We identified linkage to the COL3A1 region in a set of
families in which GORD and hiatus hernia is transmitted (fig 1).
We show genetic association for COL3A1 to GORD in a
paediatric Trio cohort and replicate the genetic association in an
adult GORD case control cohort (tables 2 and 3). We also show
genetic association between COL3A1 and hiatus hernia in the
same adult case control cohort (table 3). Our genetic findings
from these three independent patient materials are further
strengthened by the protein studies from a fourth patient
material, where the COL3A1 protein is up regulated in
oesophageal tissue biopsies taken from GORD patients in
comparison to healthy controls. We show that COL3A1 is
associated to both GORD and HH but with different alleles.
This becomes even clearer when comparing gender distribution
where only males contribute to the HH association (table 3).
The gene COL3A1 encodes type III collagen, a fibrillar mono-
trimeric extra cellular matrix protein that is present in
extensible connective tissues such as skin, lung, and the vascular
system, frequently together with type I collagen. Collagen type
III has an important role in adjusting the strength and flexibility
of tissues where it is expressed.
42 Furthermore, COL3A1 is
modulated in the wound response process. It is acutely
upregulated in the early phases of wound healing and maintains
high levels of expression for several weeks after injury. As
healing progresses, collagen type III is replaced by collagen type
I, leading to increased tissue strength.
43
A number of COL3A1 mutations cause Ehlers–Danlos
syndromes type III (EDS-III) and type IV (EDS-IV), both being
autosomal dominant connective tissue disorders. Depending on
the individual COL3A1 mutation, the severity of these diseases
can vary from mild to life threatening. Symptoms include
dermal manifestations, joint hyper-mobility and, in severe cases,
spontaneous rupture of the bowel or large arteries.
44 COL3A1
mutations similar to those underlying EDS are unlikely to be
disease-causative in patients with GORD due to the milder
phenotypic expression seen in GORD compared with EDS. One
would rather expect mutations resulting in more subtle effects
on gene function.
The genetic associations we see for haplotypes using the
assayed SNPs (table 2) are much stronger than the genetic
association seen for single SNPs (table 3). We conclude that
none of the SNPs used in this study are causative but rather in
linkage disequilibrium with the different disease alleles. We
investigated the presence of causative mutations by sequencing
the COL3A1 gene in 48 patients from the trio cohort. No
disease-associated mutation, apart from the SNPs assayed, could
be identified. Our interpretation is that the disease-causative
mutations reside in regulatory sequences.
In our genetic analysis we identify several gender differences
in the COL3A1 associations, both for GORD and HH. In the
paediatric Trio cohort, only males showed association with
GORD. In the adult case–control cohort, COL3A1 was
associated with GORD without a gender bias, whereas only
males showed association with HH. Finally, elevated collagen
type III protein staining of the oesophageal biopsies from
GORD patients was only found to be significant in males.
These differences can be attributed to differences between
our materials such as: age, population origin, gender composi-
tion and disease definition. In fact, COL3A1 itself, is partly
regulated by oestrogen.
45 This is also shown by a the decline
of collagen type III expression in post-menopausal women.
46
Additionally, a gender difference in collagen deposition during
wound healing has been reported in disease models.
47
Furthermore, male gender and increasing age has been shown
to be a risk factor for elevated wound healing times.
48 Hence,
the differences in association we observe in our analyses
may be a consequence of the biological regulation of collagen
type III.
From the data we have generated in the extended Kalixanda
cohort it is clear that two different mechanisms are at work in
COL3A1. One allele is associated with GORD while another
allele confers male susceptibility to HH. The SNP that shows
the strongest association with GORD (pcorr=0.02) shows
absolutely no evidence for association with HH (pcorr=0.94).
In this study we have an overlap of 98 patients where both
GORD and HH are present. When testing if the male HH-
associated SNP is also associated to GORD in males, the
Table 3 Genetic association of eight single nucleotide polymorphisms (SNPs) spread over collagen type III alpha I (COL3A1) in the Trio cohort and in
the extended adult case–control cohort
Number SNP
Gastro-oesophageal reflux disease Hiatus hernia
Trios, all Trios, males Case–control, all Case–control, males
p Value p Value pcorr p Value pcorr p Value pcorr
1 rs12693520 0.18 0.0167 0.08 0.85 1.00 0.45 0.95
2 rs6434304 0.042 0.0037 0.018 0.95 1.00 0.25 0.76
3 rs2056156 0.21 0.0913 0.37 0.068 0.31 0.04 0.19
4 rs3106798 0.30 0.11 0.42 0.028 0.14 0.09 0.40
5 rs7579903 0.055 0.023 0.12 0.0037 0.022 0.44 0.94
6 rs1800255 0.092 0.068 0.31 0.44 0.95 0.09 0.37
7 rs1040187 0.95 0.76 1,0 0.14 0.54 0.38 0.90
8 rs3134646 0.91 0.39 0,91 0.025 0.13 0.003 0.019
Only the males from the Trio cohort show significant genetic association for SNP number 2 after multiple testing adjustments with a pcorr of 0.018. There is no gender bias in the
adult case control cohort. Significant association for GORD in the case–control cohort was identified for SNP number 5 with a pcorr of 0.022. COL3A1 is also associated with hiatus
hernia in the adult case–control cohort. The associated SNP, number 8, has ap corr of 0.019. The identified association is male specific. The patient overlap is 98 individuals, eg,
having both GORD and hiatus hernia.
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separate disease alleles for GORD and HH.
We hypothesise that an altered collagen type III expression in
the oesophagus might lead to altered oesophageal tissue
strength and flexibility, making the oesophageal lining prone
to mucosal damage and wounds. Attenuated COL3A1 function
may impair wound healing in the oesophagus. Mutations in
COL3A1 have been shown to delay the wound healing
response.
49 An altered collagen type III expression could also
contribute to an increased risk for developing HH. An altered
collagen I/III ratio has been discussed in conjunction with HH.
50
Hiatus hernia might be a risk factor for developing GORD
through a mechanism involving increased distensibility of the
oesophagogastric junction, resulting in GORD as a secondary
event.
51 Moreover, HH formation may lead to delayed gastric
emptying, increasing the clearance time for acid refluxes in the
oesophagus.
52 We suggest that that the associated alleles of
COL3A1 are conferring increased susceptibility to both GORD
and HH, respectively.
We welcome a replication of our results from other groups to
verify our findings of COL3A1 and, hopefully, identification of
the causative mutations. We also raise the question whether
there are differences in the wound healing response in controls
versus individuals with HH due to an altered collagen I/III ratio.
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ANSWERS
From the questions on page 1047
The air pockets were also traced to the splenic vein (fig 1A,
below), inferior mesenteric vein (fig 1B) and perirectal space
(fig 1C). Enhancement of the small bowels was intact. Emergency
exploratory laparotomy on the same day as the computed
tomography (CT) scan was performed revealed turbid ascites
but intact peristalsis and vital colour of the small bowels and
colon; therefore, bowel resections were not performed.
Haemorrhagic and inflammatory change of pancreas was found.
Rubber drains were inserted and after normal saline irrigation
they drained dark bloody fluid. Subsequent colonoscopy disclosed
a short-segment mucosal tag and white-plaque coated and bullae
formationed mucosa at rectum and sigmoid colon, compatible
with ischaemic colitis. Acute necrotising pancreatitis complicated
with ischaemic colitis with aeroportia, pneumatosis coli and renal
corticalnecrosiswasdiagnosed.Oralfeedingwasresumed24 days
after operation and the patient was discharged with normalised
amylase and lipase level after a 70 day admission.
Colonic complications were more frequent in severe pancrea-
titis, occurring in 15%. The principal presentations were
necrosis, fistula and stricture. All episodes of colonic necrosis
complicated severe acute pancreatitis, were diagnosed opera-
tively, presented at a median of 25 (1–55) days into the episode
and were associated with a mortality of 54%. Surgical resection
is the mainstay of management of necrosis.
1 In this case, the
portal vein air could be traced to the inferior mesenteric vein via
the perirectal space and ischaemic colitis of rectosigmoid colon
was also confirmed in the subsequent colonoscopy. The
enhancement of small bowels and colon was intact in the CT
scans and confirmed by exploratory laparotomy.
Renalcorticalnecrosisisusuallyextensiveandbilateralowingto
decreased blood supply within the renal cortex but sparing of
medulla, juxtamedullary cortex and a thin rim of subcapsular
cortex.Themajorityofcasesareidentifiedfollowingcomplications
of late pregnancy and septic abortion. Rarely, bilateral cortical
necrosis complicating acute necrotic pancreatitis is observed.
2
Acute pancreatitis is a commonly encountered condition in
the emergency department but its complications of portal
venous air and acute renal cortical necrosis are rare. We
encountered this case with two concurrent rare complications.
Acute renal cortical necrosis was ignored due to her underlying
end-stage renal disease. The portal venous air combined with
acute and massive bowel necrosis usually has a dismal result.
When we had a careful perusal, the air was from the rectal area
via the inferior mesenteric vein into the splenic vein and portal
vein. The small and large bowels were still well-enhanced. The
surgical intervention could be reserved for any further deteriora-
tion in symptoms or signs.
Gut 2009;58:1069. doi:10.1136/gut.2008.173310a
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Figure 1 Air pockets are also noted in the splenic vein (A), inferior
mesenteric vein (B) and perirectal venous plexuses (C).
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